Corindus Vascular Robotics, Inc. - FORM 10-K - EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - March 15, 2017

Attached files

file filename
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Corindus Vascular Robotics, Inc.ex32-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Corindus Vascular Robotics, Inc.ex31-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Corindus Vascular Robotics, Inc.ex31-1.htm
EX-23.1 - CONSENT OF ERNST ? YOUNG LLP - Corindus Vascular Robotics, Inc.ex23-1.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - Corindus Vascular Robotics, Inc.ex21.htm
EX-10.42 - REGISTRATION RIGHTS AGREEMENT - Corindus Vascular Robotics, Inc.ex10-42.htm
10-K - ANNUAL REPORT - Corindus Vascular Robotics, Inc.cvrs-10k_123116.htm

 

 

Corindus Vascular Robotics, Inc. - 10-K

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Corindus Vascular Robotics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David W. Long, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

March 15, 2017

 

/s/ David W. Long    
David W. Long    
Chief Financial Officer and Senior Vice President    
Principal Financial and Accounting Officer    

 

A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section, and will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

 

 

 

 

Corindus Vascular Robotics, Inc. Reports